grazax
Botanicalexperimental
Clinical trial activity
9 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
6
Phase 3
5
Phase 4
3
Earliest trial started Nov 1, 2006 (NCT00408616)
Timeline
Indications
Approved for
Mechanism of action
- Grass allergenUnclear
Grass allergen unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- grazax
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02005627 | Phase 2 | Dec 1, 2013 | ALK-Abello, S.A., University of London, Wellcome Trust |
| NCT01854736 | Phase 4 | Apr 1, 2013 | ALK-Abello, S.A., Universidad Autonoma de Madrid |
| NCT01061203 | Phase 3 | Jan 1, 2010 | ALK-Abello, S.A., University of Turku |
| NCT02437786 | Phase 4 | Sep 1, 2009 | ALK-Abello, S.A., Universidad Autonoma de Madrid |
| NCT01740284 | Phase 3 | Sep 1, 2008 | ALK-Abello, S.A. |
| NCT00773240 | Phase 3 | Apr 1, 2008 | ALK-Abello, S.A. |
| NCT01433510 | Phase 4 | Nov 1, 2007 | ALK-Abello, S.A., University of Nantes |
| NCT00421655 | Phase 3 | Dec 1, 2006 | ALK-Abello, S.A. |
| NCT00408616 | Phase 3 | Nov 1, 2006 | ALK-Abello, S.A., Tangstedter Landstrasse, Hamburg |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ALK-Abello, S.A. | For profit | 9 | 8 | 3 | 2006 |
| Universidad Autonoma de Madrid | Academic/Hospital | 2 | 0 | 1 | 2009 |
| Tangstedter Landstrasse, Hamburg | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Nantes | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Turku | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2013 |
7 organizations
Page 1 / 1